Diagnostic Methods for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop. — CFSMEATLAS
Diagnostic Methods for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop.
Haney, Elizabeth, Smith, M E Beth, McDonagh, Marian et al. · Annals of internal medicine · 2015 · DOI
Quick Summary
This study reviewed 44 existing research papers to understand how doctors diagnose ME/CFS. Researchers found that doctors currently use nine different sets of diagnostic guidelines, and a new one was recently proposed by the Institute of Medicine. However, none of these methods have been properly tested to reliably identify ME/CFS patients in real-world situations where doctors are uncertain about the diagnosis.
Why It Matters
For patients, this review highlights why getting diagnosed with ME/CFS can be confusing—doctors may use different diagnostic criteria. For researchers, it identifies critical gaps in diagnostic validation that impede development of reliable, standardized diagnostic tools and contribute to ongoing diagnostic uncertainty in clinical practice.
Observed Findings
Nine distinct clinical case definitions have been used to diagnose ME/CFS, with a ninth recently proposed by the Institute of Medicine incorporating elements from previous definitions.
Patients meeting myalgic encephalomyelitis (ME) criteria represent a more symptomatic subset compared to the broader ME/CFS population.
Symptom rating scales successfully differentiate ME/CFS patients from healthy controls in controlled research settings.
Most diagnostic methods were evaluated only in highly selected, predefined patient populations rather than in clinical settings with diagnostic uncertainty.
Studies were limited by heterogeneous designs, small sample sizes, and variable methodological quality.
Inferred Conclusions
No current diagnostic method has been adequately tested in populations with genuine diagnostic uncertainty to establish validity and clinical utility.
More rigorous, large-scale studies in diverse, less-selected patient populations are essential to validate diagnostic criteria for routine clinical use.
The existence of multiple competing case definitions reflects ongoing disagreement about ME/CFS case definition and the need for consensus-driven research.
Remaining Questions
Which clinical criteria or combination of criteria best identifies ME/CFS patients in diverse real-world clinical populations?
What This Study Does Not Prove
This study does not prove which diagnostic criteria is best or identify a gold-standard diagnostic test for ME/CFS. It does not establish causation or mechanisms of disease, and it does not provide evidence about treatment efficacy or prognosis.